NCT07455734 2026-04-01
Early-phase Trial to Assess the Safety and Preliminary Efficacy of BNT3214 in Adults With Advanced Solid Tumors
BioNTech SE
Phase 1/2 Recruiting
BioNTech SE
HC Biopharma Inc.
LaNova Medicines Limited
HC Biopharma Inc.
Peking University